Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Brainstorm Cell Therapeutics Inc. (BCLI) had Return on Investments of 149.70% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-11.62M |
|
-- |
|
-- |
|
$11.69M |
|
$-11.69M |
|
$0.07M |
|
$-11.62M |
|
$-11.62M |
|
$-11.62M |
|
$-11.62M |
|
$-11.62M |
|
$-11.62M |
|
$-11.69M |
|
$-11.45M |
|
5.02M |
|
5.02M |
|
$-2.31 |
|
$-2.31 |
|
| Balance Sheet Financials | |
$0.39M |
|
$0.43M |
|
$1.45M |
|
$1.83M |
|
$8.98M |
|
-- |
|
$0.62M |
|
$9.60M |
|
$-7.76M |
|
$-7.76M |
|
$-7.76M |
|
6.14M |
|
| Cash Flow Statement Financials | |
$-9.09M |
|
$0.01M |
|
$7.97M |
|
$1.49M |
|
$0.37M |
|
$-1.11M |
|
$0.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
149.70% |
|
149.70% |
|
-634.44% |
|
|
Return on Investments |
149.70% |
$-1.26 |
|
$-1.81 |
|
$-1.81 |
|